IntelliPharmaCeutics International (IntelliPharmaCeutics International) Days Sales Outstanding

: 441.70 (As of Aug. 2023)

View and export this data going back to 1996. Start your Free Trial

IntelliPharmaCeutics International's average Accounts Receivable for the three months ended in Aug. 2023 was $0.33 Mil. IntelliPharmaCeutics International's Revenue for the three months ended in Aug. 2023 was $0.07 Mil. Hence, IntelliPharmaCeutics International's Days Sales Outstanding for the three months ended in Aug. 2023 was 441.70.

The historical rank and industry rank for IntelliPharmaCeutics International's Days Sales Outstanding or its related term are showing as below:

IPCIF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 4.1 Med: 49.48 Max: 176.8
Current: 73.44

During the past 13 years, IntelliPharmaCeutics International's highest Days Sales Outstanding was 176.80. The lowest was 4.10. And the median was 49.48.

IPCIF's Days Sales Outstanding is ranked worse than
50.51% of 887 companies
in the Biotechnology industry
Industry Median: 72.66 vs IPCIF: 73.44

IntelliPharmaCeutics International's Days Sales Outstanding increased from Aug. 2022 (0.00) to Aug. 2023 (441.70).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

IntelliPharmaCeutics International Days Sales Outstanding Historical Data

The historical data trend for IntelliPharmaCeutics International's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Annual Data

Trend

Nov13

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Days Sales Outstanding

98.97

21.81

31.63

5.53

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Days Sales Outstanding																-	3.04	29.81	51.90	441.70

Competitive Comparison

For the Biotechnology subindustry, IntelliPharmaCeutics International's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IntelliPharmaCeutics International Days Sales Outstanding Distribution

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's Days Sales Outstanding falls into.

IntelliPharmaCeutics International Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

IntelliPharmaCeutics International's Days Sales Outstanding for the fiscal year that ended in Nov. 2022 is calculated as

	Days Sales Outstanding (A: Nov. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Nov. 2021 )	+	Accounts Receivable (A: Nov. 2022 ))	/	count )	/	Revenue (A: Nov. 2022 )	*	Days in Period
=	( (0	+	0.001)	/	1 )	/	0.066	*	365
=	0.001					/	0.066	*	365
=	5.53

IntelliPharmaCeutics International's Days Sales Outstanding for the quarter that ended in Aug. 2023 is calculated as:

	Days Sales Outstanding (Q: Aug. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: May. 2023 )	+	Accounts Receivable (A: Aug. 2023 ))	/	count )	/	Revenue (A: Aug. 2023 )	*	Days in Period
=	( (0.334	+	0)	/	1 )	/	0.069	*	365 / 4
=	0.334					/	0.069	*	365 / 4
=	441.70

IntelliPharmaCeutics International (OTCPK:IPCIF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

IntelliPharmaCeutics International Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (OTCPK:IPCIF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

I4AA:Germany IPCI:Canada

Address

30 Worcester Road, Toronto, ON, CAN, M9W 5X2

Website

https://www.intellipharmaceutics.com

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.